Miles Capital’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$261K Sell
9,442
-42
-0.4% -$1.26K 0.28% 90
2019
Q4
$277K Buy
+9,484
New +$226K 0.22% 119
2019
Q3
Sell
-9,643
Closed -$212K 189
2019
Q2
$212K Buy
+9,643
New +$212K 0.17% 161

Other funds holding NEO

Miles Capital's NEO Position: Q1 2020 in Review

Miles Capital reduced its NeoGenomics (NEO) stake by 0.44% in Q1 2020, selling an estimated $1.26K and leaving 9,442 shares worth $261K. The position accounts for 0.28% of the portfolio, ranked #90.

Miles Capital first reported a position in NEO in Q2 2019 and has held it in 3 quarters since. The position peaked at $277K in Q4 2019. 272 funds tracked by Wall St. Rank hold NEO as of Q1 2020.

  • Miles Capital held 9,442 shares of NeoGenomics worth $261K as of Q1 2020.
  • Miles Capital sold 42 NeoGenomics shares in Q1 2020, an estimated $1.26K.
  • NeoGenomics made up 0.28% of Miles Capital's portfolio in Q1 2020, its #90 holding.
  • Miles Capital first reported a position in NeoGenomics in Q2 2019 and has held it in 3 quarters since.
  • Miles Capital's NeoGenomics position peaked at $277K in Q4 2019.
  • 272 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2020.

Based on Miles Capital's 13F filing for Q1 2020, filed 13 May 2020.